Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-051441)

Filing Details

Accession Number:: 0001209191-21-051441
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-13 17:13:46
Reporting Period:: 2021-07-08

Accepted Time:: 2021-08-13 17:13:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632384	C Joseph Galante	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-08	142	$3.18	32,559	No	4	P	Direct
Common Stock	Acquisiton	2021-07-09	142	$3.13	32,701	No	4	P	Direct
Common Stock	Acquisiton	2021-07-12	142	$3.33	32,843	No	4	P	Direct
Common Stock	Acquisiton	2021-07-13	142	$3.48	32,985	No	4	P	Direct
Common Stock	Acquisiton	2021-07-14	142	$3.33	33,127	No	4	P	Direct
Common Stock	Acquisiton	2021-07-15	142	$3.27	33,269	No	4	P	Direct
Common Stock	Acquisiton	2021-07-16	142	$3.28	33,411	No	4	P	Direct
Common Stock	Acquisiton	2021-07-19	142	$3.23	33,553	No	4	P	Direct
Common Stock	Acquisiton	2021-07-20	142	$3.24	33,695	No	4	P	Direct
Common Stock	Acquisiton	2021-07-21	142	$3.26	33,837	No	4	P	Direct
Common Stock	Acquisiton	2021-07-22	142	$3.36	33,979	No	4	P	Direct
Common Stock	Acquisiton	2021-07-23	142	$3.35	34,121	No	4	P	Direct
Common Stock	Acquisiton	2021-07-26	142	$3.39	34,263	No	4	P	Direct
Common Stock	Acquisiton	2021-07-27	142	$3.39	34,405	No	4	P	Direct
Common Stock	Acquisiton	2021-07-28	142	$3.42	34,547	No	4	P	Direct
Common Stock	Acquisiton	2021-07-29	142	$3.42	34,689	No	4	P	Direct
Common Stock	Acquisiton	2021-07-30	142	$3.31	34,831	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.